Center for Drug Evaluation and Research

Silver Spring (United States us)
Molecular Biology
Drug development Bioequivalence Pharmacokinetic/Pharmacodynamic Modeling Drug Solubility Regulatory science Drug Development Clinical endpoint Medication Adherence Clinical pharmacology Biosimilar
Watch Introduction

Bibliometric indicators

Evolution over the last years of activity

Showing the period - Sept. 2024

7,712
Activity
3%

Total documents

2.41
Impact
3%

Normalized Impact

1,768
Excellence
3%

Highly Cited Papers (Top 10%)

80.4
Leadership
3%

Leadership (%)

21.3
Mobility & Collaboration
3%

International Collaboration (%)

261
Excellence
3%

Outstanding papers (Top 1%)

19.0
Leadership
3%

Women Leading (%)

2.7
Leadership
3%

Women Leading International (%)

46.1
Open Access
3%

Open Access (%)

Main Research Fields (top 9 by publications)

Indicators:

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Net Change
3%

Human Resources

Historical perspective

From to Sept. 2024

Current resources

Quick filters

Career Stage
Occasional Junior Researcher Senior Leading
Performance
Standard Good Excellent Outstanding
Gender
Male Female
Reset
0

Personnel

0.0

Papers / Personnel

0

Leading women (%)

0
0

Gender (%)

0

Papers / Permanent researchers

0

Papers / Leading researchers

Career stage

Performance

Years of Activity

ONE Index (distribution)

ONE Index by Main Research Fields

ONE Index vs. Years of Activity

Main authors

ID Name Gender Discipline Career Stage ONE Index Years Activity NDocs RCI HCP Leader Collab.
1 Ouyang, Wenjun male Immunology Senior researcher 887 29 230 5.89 85 35.7% 23.9%
2 Lawrence X. Yu Pharmaceutical Science Leading researcher 869 34 174 3.23 55 63.2% 13.2%
3 Huang, Shiew-Mei male Pharmacology Leading researcher 838 53 212 2.65 48 46.2% 15.6%
4 Robert Philip Temple Economics and Econometrics Leading researcher 812 79 181 4.70 55 61.9% 14.4%
5 Dal Pan, Gerald male Toxicology, Economics and Econometrics Leading researcher 810 36 132 3.97 38 59.1% 11.4%
6 Zhao, Liang male Statistics and Probability Senior researcher 810 22 209 1.47 35 42.6% 23.9%
7 Verthelyi, Daniela female Immunology Leading researcher 795 32 139 2.00 34 51.8% 18.0%
8 Zidan, Ahmed male Leading researcher 794 32 71 1.71 7 62.0% 40.9%
9 Zhao, Ping male Oncology, Pharmacology Leading researcher 793 31 142 2.08 31 33.1% 25.4%
10 Mark I. Avigan Pharmacology Leading researcher 778 52 98 2.66 27 49.0% 18.4%
11 Ilyushina, Natalia female Epidemiology Senior researcher 771 24 85 1.97 25 51.8% 37.7%
12 Senior, John male Pharmacology Leading researcher 766 101 153 1.85 29 81.1% 4.6%
13 Donnelly, Raymond male Immunology Researcher 758 44 136 2.62 37 39.7% 17.7%
14 Hammad, Tarek male Public Health, Environmental and Occupational Health, Surgery Leading researcher 749 30 115 1.64 28 46.1% 16.5%
15 Elizabeth J Phillips Pharmacology, Dermatology, Immunology and Allergy Junior researcher 747 4 8 14.62 6 0.0% 75.0%
16 Krishaiah, Yellela male Pharmaceutical Science Leading researcher 744 35 100 1.37 15 71.0% 15.0%
17 Wernecke, Michael male Urology, General Health Professions, Rheumatology Junior researcher 740 1 4 0.00 0 0.0% 0.0%
18 Jerome Philip Skelly Pharmaceutical Science Leading researcher 732 52 96 2.51 15 62.5% 20.8%
19 Martin H. Cohen Oncology Leading researcher 731 118 222 3.17 66 56.3% 1.8%
20 Zhang, Xinyuan female Molecular Biology Senior researcher 723 28 146 1.98 37 38.4% 9.6%
21 Lee, Ha-Na female Molecular Biology Senior researcher 714 15 66 1.93 18 28.8% 18.2%
22 Dharmarajan, Sai male Economics and Econometrics Researcher 714 14 35 3.12 10 54.3% 20.0%
23 Lee, Sau male Researcher 710 13 40 1.73 8 30.0% 20.0%
24 David M. Frucht Immunology Leading researcher 710 34 63 4.20 20 47.6% 20.6%
25 Lionberger, Robert male Pharmaceutical Science, Economics and Econometrics Leading researcher 709 31 90 2.25 25 35.6% 16.7%
887
One Index
 Ouyang, Wenjun PhD   0000-0002-1811-5864 230 docs (1996 - 2023)  
Interleukin 22 , Proinflammatory cytokine , Innate lymphoid cell , TH17 Cells , Inflammation
869
One Index
 Lawrence X. Yu PhD 174 docs (1991 - 2024)  
Bioequivalence , Drug Solubility , Quality by Design , Biopharmaceutics , Gastrointestinal Drug Absorption
838
One Index
 Huang, Shiew-Mei PhD   0000-0003-1354-1394 212 docs (1972 - 2024)  
Drug Metabolism , Drug development , Pharmacokinetics , Pharmacogenetics , Pharmacogenomics
812
One Index
 Robert Philip Temple PhD 181 docs (1946 - 2024)  
Drug development , Drug Development , Clinical pharmacology , Availability of Medicines , Drug Development Costs
810
One Index
 Dal Pan, Gerald PhD   0000-0003-4874-5864 132 docs (1989 - 2024)  
Drug Safety Surveillance , Pharmacoepidemiology , Patient Reporting , Postmarketing surveillance , Pharmacovigilance
810
One Index
 Zhao, Liang PhD   0000-0002-0257-9082 209 docs (2003 - 2024)  
Bioequivalence , Pharmacokinetic/Pharmacodynamic Modeling , Drug development , Regulatory science , Drug Solubility
795
One Index
 Verthelyi, Daniela PhD   0000-0002-5450-3071 139 docs (1993 - 2024)  
CpG Oligodeoxynucleotide , CpG site , Bioanalysis , TLR9 , Adaptive Immunity Regulation
794
One Index
 Zidan, Ahmed PhD   0000-0002-5830-4213 71 docs (1993 - 2024)  
Drug Solubility , Skin Permeation Enhancement , Microemulsion-based Drug Delivery , Granulation , Critical quality attributes
793
One Index
 Zhao, Ping PhD   0000-0001-6106-4620 142 docs (1994 - 2024)  
Pharmacokinetics , Pharmacokinetic/Pharmacodynamic Modeling , Drug Metabolism , Pharmacogenetics , Clinical pharmacology
778
One Index
 Mark I. Avigan PhD 98 docs (1973 - 2024)  
Drug-Induced Liver Injury , Treatment , Discontinuation , Drug development , Postmarketing surveillance
771
One Index
 Ilyushina, Natalia PhD   0000-0001-8178-0472 85 docs (2001 - 2024)  
Host Immune Response , Oseltamivir , H1N1 , Neuraminidase inhibitor , H5N1 genetic structure
766
One Index
 Senior, John PhD   0000-0001-7703-4338 153 docs (1924 - 2024)  
Drug-Induced Liver Injury , Hepatotoxicity , Education , Steatorrhea , Ursodeoxycholic acid
758
One Index
 Donnelly, Raymond PhD   0000-0002-0695-5276 136 docs (1981 - 2023)  
Immune Responses , Interferon Signaling , Type I Interferons , STAT1 , Proinflammatory cytokine
749
One Index
 Hammad, Tarek PhD   0000-0001-8229-4716 115 docs (1995 - 2024)  
Pharmacoepidemiology , Birth certificate , Pregnancy , Medical record , Medication Use
747
One Index
 Elizabeth J Phillips 8 docs (2021 - 2022)  
PEGylation , Drug Hypersensitivity , Excipient , Organoid , C1-inhibitor
744
One Index
 Krishaiah, Yellela PhD   0000-0002-4844-911X 100 docs (1990 - 2020)  
Guar gum , Skin Permeation Enhancement , Transdermal Drug Delivery , Skin Penetration Enhancers , Microemulsion-based Drug Delivery
740
One Index
 Wernecke, Michael 4 docs (2024 - 2024)  
5 Alpha-Reductase Inhibitor , Alpha (finance) , Benign Prostatic Hyperplasia , Self-Efficacy , Prostate Inflammation
732
One Index
 Jerome Philip Skelly PhD 96 docs (1973 - 2024)  
Bioequivalence , Drug Solubility , Drug Development , Transdermal Drug Delivery , Pharmacodynamics
731
One Index
 Martin H. Cohen PhD 222 docs (1907 - 2020)  
Small-Cell Lung Cancer , Bronchogenic carcinoma , Regimen , Chemotherapy , Tumor Microenvironment
723
One Index
 Zhang, Xinyuan PhD   0000-0002-4636-1202 146 docs (1997 - 2024)  
Bioequivalence , Crystal Structures , Ultrasound-Assisted Crystallization , Continuous Crystallization , Structure Determination
714
One Index
 Lee, Ha-Na PhD   0000-0001-5063-6689 66 docs (2010 - 2024)  
Efferocytosis , Prostaglandin E2 , efferocytosis , Inflammation , Multiple Testing
714
One Index
 Dharmarajan, Sai PhD   0000-0002-9287-5810 35 docs (2011 - 2024)  
Sample (material) , Medication Adherence , Instrumental variable , Clinical Event Prediction , Medical Concept Embedding
710
One Index
 Lee, Sau PhD   0000-0002-6037-0121 40 docs (2012 - 2024)  
Granulation , Granule (geology) , Dry Powder Inhalers , Inhaler Devices , Quality by Design
710
One Index
 David M. Frucht PhD 63 docs (1991 - 2023)  
Inhalational Anthrax , Bacillus anthracis , Anthrax toxin , STAT4 , Immune Responses
709
One Index
 Lionberger, Robert PhD   0000-0002-0598-1771 90 docs (1994 - 2024)  
Bioequivalence , Drug Solubility , Generic drug , Gastrointestinal Drug Absorption , Regulatory science